Lynn Devilée

Lynn Devilée

Auto-generated profile, based on publicly available information

Lynn Devilée

QIMR Berghofer Medical Research Institute, Cardiac Bioengineering Laboratory, Brisbane, Australia

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2021 in Cell
Verified
Journal Article
Closed access
RMRichard J. Mills
Richard J. Mills
SHSean J. Humphrey
Sean J. Humphrey
PFPatrick R.J. Fortuna
Patrick R.J. Fortuna
MLMary Lor
Mary Lor
SFSimon R. Foster
Simon R. Foster
JHJames E. Hudson
James E. Hudson

11 January 2025 in npj Regenerative Medicine
Verified
Journal Article
Open access
PDF file
LDLynn A. C. Devilée
Lynn A. C. Devilée
ASAbou bakr Mohamed Salama
Abou bakr Mohamed Salama
JMJessica M. Miller
Jessica M. Miller
JRJanice D. Reid
Janice D. Reid
QOQinghui Ou
Qinghui Ou
RARiham Abouleisa
Riham Abouleisa
Cardiomyocytes (CMs) lost during ischemic cardiac injury cannot be replaced due to their limited proliferative capacity. Calcium is an important signal transducer that regulates key cellular processes, but its role in regulating CM proliferation is incompletely understood. Here we show a robust pathway for new calcium signaling-based cardiac regenerative strategies. A drug screen targeting proteins involved in CM calcium cycling in human embryonic stem cell-derived cardiac organoids (hCOs) revealed that only the inhibition of L-Type Calcium Channel (LTCC) induced the CM cell cycle. Furthermore, overexpression of Ras-related associated with Diabetes (RRAD), an endogenous inhibitor of LTCC, induced CM cell cycle activity in vitro, in human cardiac slices, and in vivo. Mechanistically, LTCC inhibition by RRAD or nifedipine induced CM cell cycle by modulating calcineurin activity. Moreover, ectopic expression of RRAD/CDK4/CCND in combination induced CM proliferation in vitro and in vivo, improved cardiac function and reduced scar size post-myocardial infarction.

30 November 2023 in Research Square
Verified
Preprint
Open access
PDF file
LDLynn Devilée
Lynn Devilée
JMJessica Miller
Jessica Miller
JRJanice Reid
Janice Reid
ASAbou bakr Mohamed Salama
Abou bakr Mohamed Salama
QOQinghui Ou
Qinghui Ou
RARiham Abouleisa
Riham Abouleisa
Cardiomyocytes (CMs) lost during ischemic cardiac injury cannot be replaced due to their limited proliferative capacity, which leads to progressive heart failure. Calcium (Ca2+) is an important signal transducer that regulates key cellular processes, but its role in regulating CM proliferation is incompletely understood. A drug screen targeting proteins involved in CM calcium cycling in human embryonic stem cell-derived cardiac organoids (hCOs) revealed that only the inhibition of L-Type Calcium Channel (LTCC), but not other Ca2+ regulatory proteins (SERCA or RYR), induced the CM cell cycle. Furthermore, overexpression of Ras-related associated with Diabetes (RRAD), an endogenous inhibitor of LTCC, induced CM cell cycle activity in vitro, in human cardiac slices, and in vivo. Mechanistically, LTCC inhibition by RRAD induces the cell cycle in CMs by modulating calcineurin activity and translocating Hoxb13 to the CM nucleus. Together, this represents a robust pathway for regenerative strategies.

4 August 2026 in Journal of Biological Chemistry
Verified
Journal Article
Open access
JKJames R. Krycer
James R. Krycer
SSShubhangi Seth
Shubhangi Seth
LDLynn A.C. Devilée
Lynn A.C. Devilée
MLMary Lor
Mary Lor
RFRebecca L. Fitzsimmons
Rebecca L. Fitzsimmons
SNSeverine Navarro
Severine Navarro